COMBINATION THERAPY WITH PEGYLATED INTERFERON PLUS RIBAVIRIN VERSUS PEGYLATED MONOTHERAPY IN MAJOR THALASSEMIC PATIENTS WITH CHRONIC HEPATITIS C

(1) Iran university of medical sciences, Gastrointestinal and Liver Diseases Research Centre

(2) Tehran University of Medical Sciences, Digestive Diseases Research Centre, Tehran

(3) Emam Reza hospital, Thalassemia Research Centre, Amol

(4) Iran university of medical sciences, Department of Epidemiology, Tehran, Iran (Islamic Republic of)



This item was part of the LIVER III session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A503